Pinned
I’m proud to be a 2026 Visionaries of the Year Candidate for @BloodCancerUtd. We need to raise $50,000 by June 12 to fund cancer research for hematological cancers! Please donate and share my campaign: facebook.com/donate/1937689…
Marco Ruella
826 posts
Marco Ruella
@MarcoRuella
- Amazing results in pediatric neuroblastoma of CART-GD2: CR 44%!!!! Presented by Dr.CONCETTA QUINTARELLI and Prof. Franco Locatelli at #CART23 @TheEBMT @EHA_Hematology
- Our letter to the @NEJM reporting the five-year outcomes of CART19 (CTL019, now called tisagenlecleucel) in lymphoma patients is out! Thanks to Drs. Schuster, Chong and @PennMedicine @PennCancer @Penn_IFI @carlhjune @BLLPHD
- Thanks to all collaborators who have worked at this project! @MelodySmithMD @vandenBrinkLab @Dr.facciabene @PennMedicine @MSKCancerCenter
- #CART are moving fast into autoimmunity, after the Lupus reports more reports in other autoimmune diseases... @carlhjune @PennMedicine @PEGSboston
- Congrats to @JaneWinterMD and @ASH_hematology for a great #ASH22. Great science, but also appreciated space between sessions, no 7 AM sessions, power nap pods, more food stations, coffee distributed during the plenaries, child care and much more!
- In this study, we discovered that impaired death receptor signaling in leukemia causes antigen-independent resistance to CAR T cells by causing T cell dysfunction.@NathanSinghLab1 @GillSaar @RuellaLab @carlhjune @PennMedicine @CD_AACR @NovartisNews cancerdiscovery.aacrjournals.org/content/early/…
- Our latest review on single-cell RNAseq in immunotherapy is out in @JExpMed! Thanks for this Herculean endeavour to @puneeth_guru and @RuellaLab @PennMedicine @Penn_IFIThis review by @puneeth_guru, @MarcoRuella et al. @RuellaLab @PennMedicine examines how single-cell RNA sequencing has transformed the understanding of basic #cancer and immune biology in the context of cancer #immunotherapy. bit.ly/3mslYtT #JEMCancerFocus
- Our latest crazy idea just published: "A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor positive cells" @BloodJournal @PennMedNews ashpublications.org/blood/article/…
- Tazemetostat enhances #CART immunotherapy for #NHL. @PatriziaPorazzi from our @RuellaLab presenting her newest results at #ASH23 @PennMedicine @ASHClinicalNews @kenderian_ss
- Thank you @EHA and @TheEBMT for inviting me to present at this amazing #CART meeting...but competing with @carlhjune at the meet-the-expert?!?! I did appreciate the "prof" though..
- Yunlin Zhang is ready to present her poster on a first-in-human CART19 targeting a non-FMC63 CD19 epitope with low avidity. @RuellaLab #ASH23 published today! @_ruchipatel molecular-cancer.biomedcentral.com/articles/10.11…
AT101, a new #CART with a distinct binding mechanism is showing promising early responses, according to data published today in @SN_Oncology. Poster session at #ASH23 at 5:30pm PT. @MarcoRuella @PennCancer @ASH_hematology spr.ly/6011Rz4mU - Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T cell #Immunotherapy against Cancer, by Lee, @MarcoRuella et al. bit.ly/3d06OwU @PennMedicine @PennCancer @RuellaLab
- Every year I end up celebrating my birthday at #ASH, like today! While it is tough to be far from my family, I did appreciate the thoughtful present found in my room. Thanks #ASH23! @PennMedicine
